Poor Outcome and Mortality in Patients with Lower Lung-Dominant Sarcoidosis

Table 2

Clinical characteristics in patients with lower lung-dominant sarcoidosis.

Patient no.	Age (years), gender	Smoking status	Perilymphatic nodules	Diagnostic procedure	Histology	Extrapulmonary lesions	ACE (U/L)	Treatment	Outcome
1	62, male	Ex	+	TBLB, Med	Gr, F	Skin	25.1	PSL, CsA	Died (AD)
2	60, male	Ex	+	TBLB	Gr	Eye, PG	28.7	PSL	Alive
3	70, female	Never	+	TBLB, Med	Gr, F	Eye	20.4		Alive
4	70, male	Ex	−	TBLB	Gr	—	39.3		Alive
5	72, male	Ex	−	TBLB, SL	Gr	—	20.2	PSL	Died (AD)
6	73, male	Ex	+	TBLB	Gr, F	—	11.2		Died
7	71, female	Never	+	TBLB	Gr, F	Eye	22.4		Alive
8	71, female	Never	+	TBLB	Gr	—	47.0		Alive
9	55, male	Ex	+	TBLB	Gr	—	16.9	PSL, AZP	Died (AD)
10	75, male	Ex	+	TBLB	Gr, F	Eye	15.7	PSL	Alive
11	75, male	Never	+	TBLB	Gr	Eye, skin	37.2		Alive

Ex: ex-smokers; never: never-smokers; TBLB: transbronchial lung biopsy; Med: mediastinoscopy; SL: surgical subcarinal lymphnode biopsy; Gr: granulomas; F: fibrosing mural alveolitis, PG: parotid glands; PSL: prednisolone; AZP: azathioprine; CsA: cyclosporine; AD: acute deterioration; reference [6].